Literature DB >> 16809316

Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells.

Mark A Brockman1, Admar Verschoor, Jia Zhu, Michael C Carroll, David M Knipe.   

Abstract

Replication-defective herpes simplex virus (HSV) strains elicit durable immune responses and protect against virulent HSV challenge in mice, despite being unable to establish latent infection in neuronal cells. Mechanisms for generating long-lived immunity in the absence of viral persistence remain uncertain. In animals immunized with replication-defective HSV, durable serum immunoglobulin G (IgG) responses were elicited. Surprisingly, Western blot analyses revealed that the specificities of antiviral IgG changed over time, and antibody reactivity to some viral proteins was detected only very late. Thus, some of the durable IgG activity appeared to be contributed by either new or significantly enhanced antibody responses at late times. Following immunization, radiation bone marrow-chimeric mice lacking complement receptors CD21 and CD35 on stromal cells elicited only short-lived serum IgG and failed to mount recall responses to subsequent HSV exposure. Our results suggest that complement-mediated retention of viral antigens by stromal cells, such as follicular dendritic cells, is critical for optimal maintenance of antibody responses and B-cell memory following vaccination with replication-defective HSV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809316      PMCID: PMC1489035          DOI: 10.1128/JVI.01421-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Humoral immune responses in Cr2-/- mice: enhanced affinity maturation but impaired antibody persistence.

Authors:  Z Chen; S B Koralov; M Gendelman; M C Carroll; G Kelsoe
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

2.  Memory B-cell persistence is independent of persisting immunizing antigen.

Authors:  M Maruyama; K P Lam; K Rajewsky
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

3.  Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2.

Authors:  X Da Costa; M F Kramer; J Zhu; M A Brockman; D M Knipe
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.

Authors:  C G Murphy; W T Lucas; R E Means; S Czajak; C L Hale; J D Lifson; A Kaur; R P Johnson; D M Knipe; R C Desrosiers
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Humoral response to herpes simplex virus is complement-dependent.

Authors:  X J Da Costa; M A Brockman; E Alicot; M Ma; M B Fischer; X Zhou; D M Knipe; M C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Definition of a series of stages in the association of two herpesviral proteins with the cell nucleus.

Authors:  D M Knipe; A E Spang
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection.

Authors:  A Verschoor; M A Brockman; D M Knipe; M C Carroll
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.

Authors:  C A Jones; T J Taylor; D M Knipe
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

9.  Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response.

Authors:  D Qin; J Wu; K A Vora; J V Ravetch; A K Szakal; T Manser; J G Tew
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

10.  A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease.

Authors:  M E Boursnell; C Entwisle; D Blakeley; C Roberts; I A Duncan; S E Chisholm; G M Martin; R Jennings; D Ni Challanaín; I Sobek; S C Inglis; C S McLean
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

View more
  11 in total

Review 1.  Complement-dependent transport of antigen into B cell follicles.

Authors:  Santiago F Gonzalez; Veronika Lukacs-Kornek; Michael P Kuligowski; Lisa A Pitcher; Søren E Degn; Shannon J Turley; Michael C Carroll
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

Review 2.  Viruses - from pathogens to vaccine carriers.

Authors:  Juliana C Small; Hildegund C J Ertl
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

Review 3.  Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function.

Authors:  Christopher D C Allen; Jason G Cyster
Journal:  Semin Immunol       Date:  2008-02-07       Impact factor: 11.130

4.  Murine complement receptor 1 is required for germinal center B cell maintenance but not initiation.

Authors:  Luke R Donius; Janis J Weis; John H Weis
Journal:  Immunobiology       Date:  2014-02-25       Impact factor: 3.144

Review 5.  B cell acquisition of antigen in vivo.

Authors:  Santiago F Gonzalez; Lisa A Pitcher; Thorsten Mempel; Franziska Schuerpf; Michael C Carroll
Journal:  Curr Opin Immunol       Date:  2009-06-08       Impact factor: 7.486

Review 6.  Complement and humoral immunity.

Authors:  Michael C Carroll
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

Review 7.  Herpes simplex virus as a tool to define the role of complement in the immune response to peripheral infection.

Authors:  Mark A Brockman; David M Knipe
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

8.  Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.

Authors:  Joshua J Geltz; Edward Gershburg; William P Halford
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

9.  Complement receptors 1 and 2 in murine antibody responses to IgM-complexed and uncomplexed sheep erythrocytes.

Authors:  Christian Rutemark; Anna Bergman; Andrew Getahun; Jenny Hallgren; Frida Henningsson; Birgitta Heyman
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model.

Authors:  Simon Delagrave; Hector Hernandez; Changhong Zhou; John F Hamberger; Sophia T Mundle; John Catalan; Simge Baloglu; Stephen F Anderson; Joshua M DiNapoli; Patricia Londoño-Hayes; Mark Parrington; Jeffrey Almond; Harry Kleanthous
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.